Caris Life Sciences CAI Income Statement (2024-2026)

NASDAQ CAI
$31.55 -0.20 (-0.63%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Caris Life Sciences Quarterly Income Statement

Periods 9 quarters
Latest Jun 2026

Caris Life Sciences reported revenue of $263.71M and net income of -$0.64M for the quarter ended Jun 2026, up 45.4% year over year. This income statement covers 9 quarters of results from Jun 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue 100.05M101.62M129.91M120.92M181.40M216.83M292.89M216.17M263.71M
Cost of RevenueCost of Rev 62.49M57.21M59.21M63.85M67.71M69.33M71.97M74.83M84.12M
Gross Profit 37.55M44.41M70.70M57.06M113.69M147.51M220.91M141.35M179.60M
Operating items
Research & DevelopmentR&D 24.79M27.64M27.11M23.07M25.05M21.62M31.84M31.32M32.36M
Selling, General & AdministrativeSG&A 41.07M40.85M43.11M52.12M64.37M51.97M56.51M59.71M66.55M
Other Operating ExpensesOther Opex 101.20M93.97M96.74M103.68M109.97M110.59M116.12M119.87M137.88M
Operating ExpensesOpex 167.06M162.46M166.96M178.87M199.39M184.19M204.47M210.89M236.79M
Operating IncomeOp. Inc -67.01M-60.84M-37.05M-57.95M-17.99M32.64M88.41M5.28M26.93M
EBIT -67.01M-60.84M-37.05M-57.95M-17.99M32.64M88.41M5.28M26.93M
Non-operating items
Non Operating Interest Expenses 13.67M13.80M13.26M12.78M19.21M13.51M11.36M12.81M9.23M
Interest & Investment IncomeInt & Inv Inc 2.64M1.74M0.97M0.50M1.62M7.36M7.01M6.83M6.82M
Other Non Operating IncomeOther Non Op Inc. -0.14M0.04M-0.03M-0.02M-18.34M-0.09M-2.11M0.05M-25.13M
Non Operating IncomeNon Op. Inc. 0.82M-6.89M0.10M-44.63M-53.80M-8.32M-6.45M-5.93M-27.54M
Net income details
EBT -66.19M-67.73M-36.95M-102.58M-71.79M24.32M81.96M-0.64M-0.61M
Tax ProvisionsTaxes -0.13M0.02M
Profit After TaxPAT -66.19M-67.73M-36.95M-102.58M-71.79M24.32M81.96M-0.51M-0.64M
Income from Continuing OperationsIncome (Continuing) -66.19M-67.73M-36.95M-102.58M-71.79M24.32M81.96M-0.51M-0.64M
Consolidated Net IncomeConsol Net Inc. -66.19M-67.73M-36.95M-102.58M-71.79M24.32M81.96M-0.51M-0.64M
Income towards Parent CompanyParent Net Inc -66.19M-67.73M-36.95M-102.58M-71.79M24.32M81.96M-0.51M-0.64M
Preferred Dividend PaymentsPref Dividends 23.59M24.66M25.00M24.46M384.44M
Net Income towards Common StockholdersNet Income -89.78M-92.39M-61.95M-127.04M-517.20M24.32M81.96M-0.51M-0.64M
Additional items
EPS (Basic) -2.54-2.59-1.75-3.57-7.970.090.490.000.00
EPS (Diluted) -2.54-2.59-1.75-3.57-7.970.080.490.000.00
Shares Outstanding 35.37M35.64M35.50M35.62M64.92M282.10M167.21M282.56M282.89M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 35.37M35.64M35.50M35.62M64.92M297.21M167.21M282.56M282.89M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 35.42M35.82M36.50M35.24M64.92M282.10M167.21M282.65M282.58M
EBITDA -55.41M-50.34M-27.98M-50.91M-11.59M37.54M92.70M10.38M33.43M
Interest ExpensesInt Expense 13.67M13.80M13.26M12.78M19.21M13.51M11.36M12.81M9.23M

Caris Life Sciences Income Statement API

Pull Caris Life Sciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CAI&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY